These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1862765)

  • 1. Dose-related alpha-difluoromethylornithine ototoxicity.
    Croghan MK; Aickin MG; Meyskens FL
    Am J Clin Oncol; 1991 Aug; 14(4):331-5. PubMed ID: 1862765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. alpha-difluoromethylornithine ototoxicity. Chemoprevention clinical trial results.
    Pasic TR; Heisey D; Love RR
    Arch Otolaryngol Head Neck Surg; 1997 Dec; 123(12):1281-6. PubMed ID: 9413354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal assessment of air conduction audiograms in a phase III clinical trial of difluoromethylornithine and sulindac for prevention of sporadic colorectal adenomas.
    McLaren CE; Fujikawa-Brooks S; Chen WP; Gillen DL; Pelot D; Gerner EW; Meyskens FL
    Cancer Prev Res (Phila); 2008 Dec; 1(7):514-21. PubMed ID: 19139001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II study of alpha-difluoromethylornithine (DFMO) for the treatment of metastatic melanoma.
    Meyskens FL; Kingsley EM; Glattke T; Loescher L; Booth A
    Invest New Drugs; 1986; 4(3):257-62. PubMed ID: 3102397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of difluoromethylornithine chemoprevention on audiometry thresholds and otoacoustic emissions.
    Doyle KJ; McLaren CE; Shanks JE; Galus CM; Meyskens FL
    Arch Otolaryngol Head Neck Surg; 2001 May; 127(5):553-8. PubMed ID: 11346432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carboplatin is ototoxic.
    Kennedy IC; Fitzharris BM; Colls BM; Atkinson CH
    Cancer Chemother Pharmacol; 1990; 26(3):232-4. PubMed ID: 2192812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of alpha-difluoromethylornithine on rectal mucosal levels of polyamines in a randomized, double-blinded trial for colon cancer prevention.
    Meyskens FL; Gerner EW; Emerson S; Pelot D; Durbin T; Doyle K; Lagerberg W
    J Natl Cancer Inst; 1998 Aug; 90(16):1212-8. PubMed ID: 9719082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I trial of recombinant interferon-alpha and alpha-difluoromethylornithine in metastatic melanoma.
    Croghan MK; Booth A; Meyskens FL
    J Biol Response Mod; 1988 Aug; 7(4):409-15. PubMed ID: 3139843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin ototoxicity: the importance of baseline audiometry.
    Nagy JL; Adelstein DJ; Newman CW; Rybicki LA; Rice TW; Lavertu P
    Am J Clin Oncol; 1999 Jun; 22(3):305-8. PubMed ID: 10362343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ototoxicity of Long-Term α-Difluoromethylornithine for Skin Cancer Prevention.
    Chow CL; Havighurst T; Lozar T; Jones TD; Kim K; Bailey HH
    Laryngoscope; 2023 Mar; 133(3):676-682. PubMed ID: 35620919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irreversible ototoxicity associated with difluoromethylornithine.
    Lao CD; Backoff P; Shotland LI; McCarty D; Eaton T; Ondrey FG; Viner JL; Spechler SJ; Hawk ET; Brenner DE
    Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1250-2. PubMed ID: 15247138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difluoromethylornithine and leukocyte interferon: a phase I study in cancer patients.
    Talpaz M; Plager C; Quesada J; Benjamin R; Kantarjian H; Gutterman J
    Eur J Cancer Clin Oncol; 1986 Jun; 22(6):685-9. PubMed ID: 3091371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity evaluation of difluoromethylornithine: doses for chemoprevention trials.
    Loprinzi CL; Messing EM; O'Fallon JR; Poon MA; Love RR; Quella SK; Trump DL; Morton RF; Novotny P
    Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):371-4. PubMed ID: 9162303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of alpha-difluoromethylornithine as a potential chemopreventive agent: tolerance to daily oral administration in humans.
    Creaven PJ; Pendyala L; Petrelli NJ
    Cancer Epidemiol Biomarkers Prev; 1993; 2(3):243-7. PubMed ID: 8318877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ototoxicity due to cis-diamminedichloroplatinum in the treatment of ovarian cancer: influence of dosage and schedule of administration.
    Waters GS; Ahmad M; Katsarkas A; Stanimir G; McKay J
    Ear Hear; 1991 Apr; 12(2):91-102. PubMed ID: 2065844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I study of hepatic arterial infusion using difluoromethylornithine.
    Lipton A; Harvey HA; Glenn J; Weidner WA; Strauss M; Miller SE; Taylor JB; White-Hershey D; Barlow JL
    Cancer; 1989 Feb; 63(3):433-7. PubMed ID: 2492203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I study of alpha-difluoromethylornithine and methyl-GAG.
    Splinter TA; Romijn JC
    Eur J Cancer Clin Oncol; 1986 Jan; 22(1):61-7. PubMed ID: 3082642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
    Levin VA; Uhm JH; Jaeckle KA; Choucair A; Flynn PJ; Yung WKA ; Prados MD; Bruner JM; Chang SM; Kyritsis AP; Gleason MJ; Hess KR
    Clin Cancer Res; 2000 Oct; 6(10):3878-84. PubMed ID: 11051233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose de-escalation chemoprevention trial of alpha-difluoromethylornithine in patients with colon polyps.
    Meyskens FL; Emerson SS; Pelot D; Meshkinpour H; Shassetz LR; Einspahr J; Alberts DS; Gerner EW
    J Natl Cancer Inst; 1994 Aug; 86(15):1122-30. PubMed ID: 8028034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cochlear damage and increased threshold in alpha-difluoromethylornithine (DFMO) treated guinea pigs.
    Salzer SJ; Mattox DE; Brownell WE
    Hear Res; 1990 Jun; 46(1-2):101-12. PubMed ID: 2116404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.